The ECG app on Apple Watch Series 4, a direct-to-consumer product that enables customers to take an electrocardiogram right from their wrist, is available in Hong Kong and 19 European countries, including France, Germany, Italy, Spain and the United Kingdom. In addition to receiving de Novo clearance in the US from the FDA, the ECGweiterlesen

Available today as part of a free update to watchOS 5.1.2, the ECG app and irregular heart rhythm notification feature will help users identify signs of AFib, the most common form of irregular rhythm. Apple worked with the Food and Drug Administration (FDA) for a number of years to receive De Novo classification for theweiterlesen